Jim Huebner
Director, Program Management | Boston, Massachusetts, United States
*50 free lookup(s) per month.
No credit card required.
Jim Huebner’s Emails jh****@dy****.com
Jim Huebner’s Phone Numbers +1781786****
Social Media
Jim Huebner’s Location Boston, Massachusetts, United States
Jim Huebner’s Expertise Director, Program Management
Jim Huebner’s Current Industry Dyne Therapeutics
Jim
Huebner’s Prior Industry
Pharmacia Corporation (Now Pfizer)
|
Otsuka
|
Biovail Corporation (Acquired by Valiant Pharmaceuticals)
|
Barrier Therapeutics (Acquired by Stiefel in 2008)
|
Dr. Reddy's Laboratories (Re-Branded as Promius Pharma)
|
ReSearch Pharmaceutical Services (Acquired by PRA)
|
Millennium Pharmaceuticals (Now Takeda Oncology)
|
TESARO, Inc. (Now a Subsidiary of GlaxoSmithKline (GSK))
|
Celldex Therapeutics
|
Centrexion Therapeutics Corp.
|
Epizyme (Acquired by Ipsen in 2022)
|
Radius Health Services, Inc. (Acquired by Gurnet Point and Patient Square Capital in 2022)
|
Talaris Therapeutics (Ceased independent operations in early 2023)
|
Dyne Therapeutics
Not the Jim Huebner you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience
Dyne Therapeutics
Director, Program Management
2023-04-01 — Present
Talaris Therapeutics (Ceased independent operations in early 2023)
Director, Program Management
2022-09-01 — 2023-02-01
Radius Health Services, Inc. (Acquired by Gurnet Point and Patient Square Capital in 2022)
Director of Strategy and Program Mgmt
2022-04-01 — 2022-08-01
Epizyme (Acquired by Ipsen in 2022)
Director/Clinical Program Leader (Hematologic Malignancies)
2019-07-01 — 2021-12-01
Centrexion Therapeutics Corp.
Senior Director, Strategic Planning and Business Operations (Pain Management)
2018-07-01 — 2019-04-01
Centrexion Therapeutics Corp.
Project Management Consultant
2018-04-01 — 2018-06-01
Celldex Therapeutics
Director, Project Management (Oncology)
2015-12-01 — 2018-02-01
TESARO, Inc. (Now a Subsidiary of GlaxoSmithKline (GSK))
Lead Portfolio Analyst, Portfolio Management (Oncology)
2013-07-01 — 2015-11-01
TESARO, Inc. (Now a Subsidiary of GlaxoSmithKline (GSK))
Sr. Program Manager\Program Leader (Oncology)
2011-12-01 — 2013-06-01
Millennium Pharmaceuticals (Now Takeda Oncology)
Associate Director, Drug Development Management (Oncology)
2009-07-01 — 2011-12-01
ReSearch Pharmaceutical Services (Acquired by PRA)
Associate Director Early Development
2006-07-01 — 2009-07-01
Dr. Reddy's Laboratories (Re-Branded as Promius Pharma)
Director, Project Management (Dermatology)
2005-12-01 — 2006-07-01
Barrier Therapeutics (Acquired by Stiefel in 2008)
Global Project Manager II/Project Leader (Dermatology)
2005-01-01 — 2005-01-01
Biovail Corporation (Acquired by Valiant Pharmaceuticals)
Program Manager
2003-01-01 — 2005-01-01
Otsuka
Manager, Project Planning and Commercial Development
2002-01-01 — 2003-01-01
Pharmacia Corporation (Now Pfizer)
Research Biologist and Project Planner
1997-01-01 — 2002-01-01Skills
Languages
Jim Huebner Email Addresses
Jim Huebner Phone Number
FAQ About Jim Huebner
-
Jim Huebner is located at
Boston, Massachusetts, United States -
Jim Huebner is a
Director, Program Management Dyne Therapeutics -
Jim Huebner currently works in the
Dyne Therapeutics -
Jim Huebner specializes in
Director, Program Management -
Jim Huebner speaks the following languages:
No languages available. -
Jim Huebner has prior experience in the following industries:
Talaris Therapeutics (Ceased independent operations in early 2023) , Radius Health Services, Inc. (Acquired by Gurnet Point and Patient Square Capital in 2022) , Epizyme (Acquired by Ipsen in 2022) , Centrexion Therapeutics Corp. , Centrexion Therapeutics Corp. , Celldex Therapeutics , TESARO, Inc. (Now a Subsidiary of GlaxoSmithKline (GSK)) , TESARO, Inc. (Now a Subsidiary of GlaxoSmithKline (GSK)) , Millennium Pharmaceuticals (Now Takeda Oncology) , ReSearch Pharmaceutical Services (Acquired by PRA) , Dr. Reddy's Laboratories (Re-Branded as Promius Pharma) , Barrier Therapeutics (Acquired by Stiefel in 2008) , Biovail Corporation (Acquired by Valiant Pharmaceuticals) , Otsuka , Pharmacia Corporation (Now Pfizer) -
Jim Huebner has the following professional experience:
Dyne Therapeutics , Talaris Therapeutics (Ceased independent operations in early 2023) , Radius Health Services, Inc. (Acquired by Gurnet Point and Patient Square Capital in 2022) , Epizyme (Acquired by Ipsen in 2022) , Centrexion Therapeutics Corp. , Centrexion Therapeutics Corp. , Celldex Therapeutics , TESARO, Inc. (Now a Subsidiary of GlaxoSmithKline (GSK)) , TESARO, Inc. (Now a Subsidiary of GlaxoSmithKline (GSK)) , Millennium Pharmaceuticals (Now Takeda Oncology) , ReSearch Pharmaceutical Services (Acquired by PRA) , Dr. Reddy's Laboratories (Re-Branded as Promius Pharma) , Barrier Therapeutics (Acquired by Stiefel in 2008) , Biovail Corporation (Acquired by Valiant Pharmaceuticals) , Otsuka , Pharmacia Corporation (Now Pfizer) . -
You can view Jim Huebner’s
LinkedIn profile at LinkedIn URL. -
Jim Huebner’s work email addresses are
[email protected] . -
Jim Huebner works at
Dyne Therapeutics
People you may be interested in
- Alan Ding
- Araselia Barrera
- Tom Hagen
- Matthew Tompkins
- Md Mobarak Hossain
- Pablo Montoya
Location Quality Manager at Worleyparsons
Director of Patient Care Services
Early Retiree at On the bank of a quiet pond, fishing pole in hand. Recruiters: Shoo...go away! I'm done.
Senior Manager - National Development
Chief Executive, Marga Net One Ltd.
Planner Projects IM&S RPC México at John Deere